Masuda M - Search Results

1

Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.

Suzui M, Masuda M, Lim JT, Albanese C, Pestell RG, Weinstein IB. Suzui M, et al. Among authors: masuda m. Cancer Res. 2002 Jul 15;62(14):3997-4006. Cancer Res. 2002. PMID: 12124333

2

The roles of JNK1 and Stat3 in the response of head and neck cancer cell lines to combined treatment with all-trans-retinoic acid and 5-fluorouracil.

Masuda M, Toh S, Koike K, Kuratomi Y, Suzui M, Deguchi A, Komiyama S, Weinstein IB. Masuda M, et al. Jpn J Cancer Res. 2002 Mar;93(3):329-39. doi: 10.1111/j.1349-7006.2002.tb02176.x. Jpn J Cancer Res. 2002. PMID: 11927016 Free PMC article.

3

Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.

Masuda M, Suzui M, Yasumatu R, Nakashima T, Kuratomi Y, Azuma K, Tomita K, Komiyama S, Weinstein IB. Masuda M, et al. Cancer Res. 2002 Jun 15;62(12):3351-5. Cancer Res. 2002. PMID: 12067972

4

Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction.

Masuda M, Suzui M, Lim JT, Deguchi A, Soh JW, Weinstein IB. Masuda M, et al. J Exp Ther Oncol. 2002 Nov-Dec;2(6):350-9. doi: 10.1046/j.1359-4117.2002.01062.x. J Exp Ther Oncol. 2002. PMID: 12440226

5

Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells.

Masuda M, Suzui M, Lim JT, Weinstein IB. Masuda M, et al. Clin Cancer Res. 2003 Aug 15;9(9):3486-91. Clin Cancer Res. 2003. PMID: 12960141

6

Acyclic retinoid activates retinoic acid receptor beta and induces transcriptional activation of p21(CIP1) in HepG2 human hepatoma cells.

Suzui M, Shimizu M, Masuda M, Lim JT, Yoshimi N, Weinstein IB. Suzui M, et al. Among authors: masuda m. Mol Cancer Ther. 2004 Mar;3(3):309-16. Mol Cancer Ther. 2004. PMID: 15026551

7

Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells.

Lim JT, Joe AK, Suzui M, Shimizu M, Masuda M, Weinstein IB. Lim JT, et al. Among authors: masuda m. Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3478-84. doi: 10.1158/1078-0432.CCR-05-2051. Clin Cancer Res. 2006. PMID: 16740773

8

Effects of a novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ), on growth, apoptosis, gene expression, and chemosensitivity in head and neck squamous cell carcinoma cell lines.

Ruan HY, Masuda M, Ito A, Umezawa K, Nakashima T, Yasumatsu R, Kuratomi Y, Yamamoto T, Weinstein IB, Komune S. Ruan HY, et al. Among authors: masuda m. Head Neck. 2006 Feb;28(2):158-65. doi: 10.1002/hed.20304. Head Neck. 2006. PMID: 16355386

9

Signal transducers and activators of transcription 3 up-regulates vascular endothelial growth factor production and tumor angiogenesis in head and neck squamous cell carcinoma.

Masuda M, Ruan HY, Ito A, Nakashima T, Toh S, Wakasaki T, Yasumatsu R, Kutratomi Y, Komune S, Weinstein IB. Masuda M, et al. Oral Oncol. 2007 Sep;43(8):785-90. doi: 10.1016/j.oraloncology.2006.10.007. Epub 2006 Dec 13. Oral Oncol. 2007. PMID: 17169602

10

Somatic evolution of head and neck cancer - biological robustness and latent vulnerability.

Masuda M, Toh S, Wakasaki T, Suzui M, Joe AK. Masuda M, et al. Mol Oncol. 2013 Feb;7(1):14-28. doi: 10.1016/j.molonc.2012.10.009. Epub 2012 Nov 2. Mol Oncol. 2013. PMID: 23168041 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,703 results

Search Page

Filters